Biofutures: Race and the governance of health

Abstract

This article addresses biomedical forms of racial targeting under neoliberal biopolitics. We explore two racial targeting technologies: The development of race-based pharmaceuticals, specifically BiDil; and medical hot spotting, a practice that uses Geographic Information System (GIS) technologies and spatial profiling to identify populations that are medically vulnerable in order to facilitate preemptive care. These technologies are ostensibly deployed under neoliberal biopolitics and the governance of health to affirm life. We argue, however, that these efforts further subject racial minorities—and specifically black subjects—to the cost–benefit logics of neoliberalism in the U.S. health care system and enduring anti-blackness. What is called for is an abolitionist biomedicine that recognizes and seeks to challenge the multifarious ways that race is ontologized as a corporeal and/or spatial truth while attending to the very real embodied effects of structural racism.